Advanced Glycation End Products (AGEs) Inhibit Macrophage Efferocytosis of Apoptotic β Cells through Binding to the Receptor for AGEs

Abstract

Pancreatic β cell apoptosis is important in the pathogenesis of type 2 diabetes mellitus (T2DM). Generally, apoptotic β cells are phagocytosed by macrophages in a process known as “efferocytosis.” Efferocytosis is critical to the resolution of inflammation and is impaired in T2DM. Advanced glycation end products (AGEs), which are increased in T2DM, are known to suppress phagocytosis function in macrophages. In this study, we found that AGEs inhibited efferocytosis of apoptotic β cells by primary peritoneal macrophages in C57BL/6J mice or mouse macrophage cell line Raw264.7. Mechanistically, AGEs inhibit efferocytosis by blocking Ras-related C3 botulinum toxin substrate 1 activity and cytoskeletal rearrangement through receptor for advanced glycation end products/ras homolog family member A/Rho kinase signaling in macrophages. Furthermore, it was observed that AGEs decreased the secretion of anti-inflammatory factors and promoted the proinflammatory ones to modulate the inflammation function of efferocytosis. Taken together, our results indicate that AGEs inhibit efferocytosis through binding to receptor for advanced glycation end products and activating ras homolog family member A/Rho kinase signaling, thereby inhibiting the anti-inflammatory function of efferocytosis.

Exosomal MALAT1 promotes the proliferation of esophageal squamous cell carcinoma through glyoxalase 1-dependent methylglyoxal removal

“…AGEs can directly produce deleterious effects or exert their damaging effects through the receptors of AGEs (RAGEs). Both MGO and AGEs can induce the most deleterious consequences directly or by stimulating RAGE signaling [ 27 , 28 ].…”

IDN5706 Inhibits Synovial Inflammation via Inducing M2 Polarization of Synovial Macrophages in Osteoarthritis Rats

“…In addition to macrophage polarization, in this study, we also assessed the efferocytosis of macrophages. Efferocytosis described the process by which the apoptotic cells were engulfed and digested by phagocytes, especially macrophages, and without efferocytosis, the apoptotic cells underwent necrosis and released harmful cell products, resulting in an excessive inflammatory response [28,29]. The growth arrest specific gene 6 (Gas6)/protein S (ProS)-TAM system consisted of two vitamin K-dependent ligands (Gas6, ProS) and three receptor tyrosine kinases (TYRO3 protein tyrosine kinase [Tyro3], AXL receptor tyrosine kinase [Axl], and c-mer proto-oncogene tyrosine kinase [MERTK], which were collectively referred to as TAM receptors) that participated in efferocytosis [30,31].…”

Targeting Macrophages: Therapeutic Approaches in Diabetic Kidney Disease

“…In vivo studies showed reduced phagocytosis of apoptotic neutrophils by macrophages in RAGE-deficient mice [109]. Elevated AGEs in type 2 diabetes inhibit macrophage phagocytosis by disrupting RAC-1 activity and cytoskeletal rearrangement through RAGE/Rho kinase signaling in macrophages [110].…”